Cradle Raises $24 Million Series A Investment for AI Biotech

This chapter discusses Dutch biotech startup Cradle's recent $24 million series A investment to scale up its generative AI biotech business. It explains how Cradle's software helps make drug development faster and cheaper by creating proteins with desired properties, and how they use generative AI models to analyze data and find ideal proteins for drug developers.